Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
RVNC holding history
Revance Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVNC overviewAll 13F holders of RVNCFull Q1 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −144,365−100.0% | Sold out | Holders |
| Q2 2024 | 144,365 | $371.0K | 0.1% | −30,502−17.4% | Reduced | Holders |
| Q1 2024 | 174,867 | $860.3K | 0.2% | +69,572+66.1% | Added | Holders |
| Q4 2023 | 105,295 | $925.5K | 0.3% | +105,295 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −11,619−100.0% | Sold out | Holders |
| Q2 2023 | 11,619 | $294.1K | 0.2% | +11,619 | New | Holders |